Schedule 13G ownership disclosure

G1 THERAPEUTICS INC

Security class unavailable · CUSIP: 3621LQ109

Event date: 2024-09-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-24-000655
Form type
SC 13G/A
Filer
Beryl Capital Management LLC
CIK
CIK 1719307
Filed
Nov 13, 2024
Reporting period
Sep 30, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub